Literature DB >> 22311973

Toxin-induced RhoA activity mediates CCL1-triggered signal transducers and activators of transcription protein signaling.

Simone Reipschläger1, Katharina Kubatzky, Sanaz Taromi, Meike Burger, Joachim Orth, Klaus Aktories, Gudula Schmidt.   

Abstract

RhoA is reportedly involved in signal transducers and activators of transcription (STAT)-dependent transcription. However, the pathway connecting the GTPase and STAT signaling has not been characterized. Here, we made use of bacterial toxins, which directly activate Rho GTPases to analyze this pathway. Cytotoxic necrotizing factors (CNFs) are produced by pathogenic Escherichia coli strains and by Yersinia pseudotuberculosis. They activate small GTPases of the Rho family by deamidation of a glutamine, which is crucial for GTP hydrolysis. We show that RhoA activation leads to phosphorylation and activation of STAT3 and identify signal proteins involved in this pathway. RhoA-dependent STAT3 stimulation requires ROCK and Jun kinase activation as well as AP1-induced protein synthesis. The secretion of one or more factors activates the JAK-STAT pathway in an auto/paracrine manner. We identify CCL1/I-309 as an essential cytokine, which is produced and secreted upon RhoA activation and which is able to activate STAT3-dependent signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22311973      PMCID: PMC3322882          DOI: 10.1074/jbc.M111.313395

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  Rho GTPases.

Authors:  D J Mackay; A Hall
Journal:  J Biol Chem       Date:  1998-08-14       Impact factor: 5.157

2.  Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1: activation of c-Jun N-terminal kinase in HeLa cells.

Authors:  M Lerm; J Selzer; A Hoffmeyer; U R Rapp; K Aktories; G Schmidt
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

3.  Stat3 activation is required for cellular transformation by v-src.

Authors:  J F Bromberg; C M Horvath; D Besser; W W Lathem; J E Darnell
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

Review 4.  STATs and gene regulation.

Authors:  J E Darnell
Journal:  Science       Date:  1997-09-12       Impact factor: 47.728

5.  Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine.

Authors:  G Flatau; E Lemichez; M Gauthier; P Chardin; S Paris; C Fiorentini; P Boquet
Journal:  Nature       Date:  1997-06-12       Impact factor: 49.962

Review 6.  Necrotoxic Escherichia coli (NTEC): two emerging categories of human and animal pathogens.

Authors:  J De Rycke; A Milon; E Oswald
Journal:  Vet Res       Date:  1999 Mar-Jun       Impact factor: 3.683

7.  Role of Rho protein in lovastatin-induced breakdown of actin cytoskeleton.

Authors:  G Koch; C Benz; G Schmidt; C Olenik; K Aktories
Journal:  J Pharmacol Exp Ther       Date:  1997-11       Impact factor: 4.030

8.  Evidence for two types of cytotoxic necrotizing factor in human and animal clinical isolates of Escherichia coli.

Authors:  J De Rycke; E A González; J Blanco; E Oswald; M Blanco; R Boivin
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

9.  Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor.

Authors:  A Sotiropoulos; S Moutoussamy; F Renaudie; M Clauss; C Kayser; F Gouilleux; P A Kelly; J Finidori
Journal:  Mol Endocrinol       Date:  1996-08

10.  Identification of CCR8: a human monocyte and thymus receptor for the CC chemokine I-309.

Authors:  H L Tiffany; L L Lautens; J L Gao; J Pease; M Locati; C Combadiere; W Modi; T I Bonner; P M Murphy
Journal:  J Exp Med       Date:  1997-07-07       Impact factor: 14.307

View more
  7 in total

1.  IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality.

Authors:  Hong Zhang; Patrick Neuhöfer; Liang Song; Björn Rabe; Marina Lesina; Magdalena U Kurkowski; Matthias Treiber; Thomas Wartmann; Sara Regnér; Henrik Thorlacius; Dieter Saur; Gregor Weirich; Akihiko Yoshimura; Walter Halangk; Joseph P Mizgerd; Roland M Schmid; Stefan Rose-John; Hana Algül
Journal:  J Clin Invest       Date:  2013-02-15       Impact factor: 14.808

2.  ErbB targeting inhibitors repress cell migration of esophageal squamous cell carcinoma and adenocarcinoma cells by distinct signaling pathways.

Authors:  Christiane D Fichter; Verena Gudernatsch; Camilla M Przypadlo; Marie Follo; Gudula Schmidt; Martin Werner; Silke Lassmann
Journal:  J Mol Med (Berl)       Date:  2014-08-06       Impact factor: 4.599

3.  [RhoA/Rho-kinase contributes to chronic pain following thoracotomy by up-regulating glutaminase 1 expression in rat spinal dorsal cord].

Authors:  Zi-Yan Liu; Hai-Tang Wang; Jing Tang; Zai-Sheng Qin
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-10-20

Review 4.  The Regulatory Role of Reticulons in Neurodegeneration: Insights Underpinning Therapeutic Potential for Neurodegenerative Diseases.

Authors:  Lilesh Kumar Pradhan; Saroj Kumar Das
Journal:  Cell Mol Neurobiol       Date:  2020-06-05       Impact factor: 5.046

5.  From a traditional medicinal plant to a rational drug: understanding the clinically proven wound healing efficacy of birch bark extract.

Authors:  Sandra Ebeling; Katrin Naumann; Simone Pollok; Tina Wardecki; Sabine Vidal-Y-Sy; Juliana M Nascimento; Melanie Boerries; Gudula Schmidt; Johanna M Brandner; Irmgard Merfort
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

6.  Activation of RhoA,B,C by Yersinia Cytotoxic Necrotizing Factor (CNFy) induces apoptosis in LNCaP prostate cancer cells.

Authors:  Anke Augspach; Joachim H List; Philipp Wolf; Heike Bielek; Carsten Schwan; Ursula Elsässer-Beile; Klaus Aktories; Gudula Schmidt
Journal:  Toxins (Basel)       Date:  2013-11-21       Impact factor: 4.546

Review 7.  The Cytotoxic Necrotizing Factors (CNFs)-A Family of Rho GTPase-Activating Bacterial Exotoxins.

Authors:  Paweena Chaoprasid; Petra Dersch
Journal:  Toxins (Basel)       Date:  2021-12-15       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.